Stock Taper
OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS
PROK
PROKIDNEY CORP.
NASDAQ
$1.81
▲ UP 0.56% (0.01)

KEY STATISTICS

Market Cap$605.26 M
52w High$3.48
52w Low$1.30
Dividend Yield—
Frequency—
P/E-3.42
Volume950.92K
Shares Out.148.17M

COMPANY

LEADERSHIP

Bruce Culleton
CHIEF EXECUTIVE
Bruce Culleton

COMPENSATION 2026

Salary$687,738
Stock Awards$0
Incentive Plan Pay$478,080
All Other Comp.$15,463
Total$2,956,447

ABOUT

SECTOR
Healthcare
WENT PUBLIC
June 30, 2021
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
231

PRICE TARGET

Target High$6.00
Target Low$3.00
Target Median$5.00
Target Consensus$4.67

UPCOMING EARNINGS

DateNov 9, 2026
DayMonday
Rev. Est.$124.60K
NOV
9
MON

PRICE

$1.81 ▲ UP 0.56% (+$0.01)
$1.80$1.81$1.839:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM1.81

About ProKidney Corp.

https://www.prokidney.com ↗

ProKidney Corp., founded in 2015 in Winston-Salem, NC, is a clinical-stage biotech developing cellular therapies, including Renal Autologous Cell Therapy for diabetic kidney disease and congenital kidney anomalies.

INDUSTRY

Biotechnology

A PRODUCT PROKIDNEY CORP. IS KNOWN FOR

rilparencel (REACT®)
rilparencel (REACT®)

Rilparencel, a proprietary autologous cellular therapy by ProKidney, is in Phase 3 trials for CKD and type 2 diabetes patients at high risk of kidney failure, with FDA RMAT designation.

COMPETITORS

COMPETITOR
CRSP COMPARE
MAZE COMPARE
MESO COMPARE
TVTX COMPARE
VERA COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
38
LISTED HERE
10
RANKED BY POSITION SIZE
IWM
0.00% · 1.7M
VXF
0.00% · 1.3M
SCHA
0.00% · 501.0K
SURI
0.54% · 244.5K
BBC
0.74% · 193.5K
XRS2.DE
0.00% · 67.0K
RSSL
0.00% · 35.9K
RTYS.L
0.00% · 8.4K
URTY
0.00% · 3.0K
FSEG
0.06% · 2.2K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
26.47%
HOLDERS
84
TOP 12 OF 84 · RANKED BY POSITION SIZE
Suvretta Capital Management, LLC
12.3M sh · $22.09M
Morgan Stanley
9.0M sh · $16.03M
Blackrock Inc.
3.7M sh · $8.99M
Millennium Management LLC
2.3M sh · $4.07M
Bleichroeder LP
2.0M sh · $3.58M
Artia Global Partners LP
1.8M sh · $4.12M
Vanguard Group Inc
1.6M sh · $3.69M
Hennion & Walsh Asset Management, Inc.
1.6M sh · $2.88M
Blackrock, Inc.
1.4M sh · $3.15M
Renaissance Technologies LLC
1.3M sh · $2.24M
Geode Capital Management, LLC
1.2M sh · $2.2M
Marshall Wace, Llp
1.0M sh · $1.81M

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity4
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
DIRECTOR
Pereira Brian JG
Sale · 222.9K shares
2026-08-19
★
DIRECTOR
Pereira Brian JG
Sale · 27.8K shares
2026-08-18
★
DIRECTOR
Pereira Brian JG
Sale · 27.1K shares
2026-08-20
★
DIRECTOR
Pereira Brian JG
Sale · 229.3K shares
2026-08-18

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS
HC Wainwright & Co. BUY

SECTORS PEERS

PEERPRICE
TNGX$24.30COMPARE
NBTX$36.02COMPARE
SEPN$39.68COMPARE
BCAX$23.55COMPARE
TYRA$25.42COMPARE
SVRA$5.41COMPARE
KURA$11.58COMPARE
PRME$3.23COMPARE